P652: MEASURING MINIMAL RESIDUAL DISEASE BEYOND 10-4 THROUGH IGHV LEADER-BASED NEXT GENERATION SEQUENCING IMPROVES PROGNOSTIC STRATIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA

• P. Hengeveld,
• M. van der Klift,
• P. M. Kolijn,
• F. Davi,
• F. Kavelaars,
• E. de Jonge,
• S. Robrecht,
• J. Assmann,
• L. van der Straten,
• M. Ritgen,
• P. Westerweel,
• K. Fischer,
• V. Goede,
• M. Hallek,
• M.-D. Levin,
• A. Langerak

Affiliations

P. Hengeveld

1 Department of Immunology, Erasmus MC, Rotterdam

M. van der Klift

1 Department of Immunology, Erasmus MC, Rotterdam

P. M. Kolijn

1 Department of Immunology, Erasmus MC, Rotterdam

F. Davi

3 Department of Hematology, Pitié-Salpêtrière Hospital, Paris, France

F. Kavelaars

4 Department of Hematology

E. de Jonge

5 Department of Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands

S. Robrecht

6 Department I. of Internal Medicine, Center for Intergrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne

J. Assmann

1 Department of Immunology, Erasmus MC, Rotterdam

L. van der Straten

1 Department of Immunology, Erasmus MC, Rotterdam

M. Ritgen

7 Department of Medicine II, University Hospital of Schleswig Holstein, Kiel

P. Westerweel

2 Department of Internal Medicine, Albert Schweizer Ziekenhuis, Dordrecht, Netherlands

K. Fischer

6 Department I. of Internal Medicine, Center for Intergrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne

V. Goede

8 Division of Oncogeriatrics, St Marien Hospital, Cologne, Germany

M. Hallek

6 Department I. of Internal Medicine, Center for Intergrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne

M.-D. Levin

2 Department of Internal Medicine, Albert Schweizer Ziekenhuis, Dordrecht, Netherlands

A. Langerak

1 Department of Immunology, Erasmus MC, Rotterdam